184 related articles for article (PubMed ID: 38370408)
1. The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis.
Wu S; Liu M; Zhang M; Ye X; Gu H; Jiang C; Zhu H; Ye X; Li Q; Huang X; Cao M
Front Immunol; 2024; 15():1275064. PubMed ID: 38370408
[TBL] [Abstract][Full Text] [Related]
2. Underlying Molecular Mechanism and Construction of a miRNA-Gene Network in Idiopathic Pulmonary Fibrosis by Bioinformatics.
Zheng S; Zhang Y; Hou Y; Li H; He J; Zhao H; Sun X; Liu Y
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686108
[TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis-related genes and potential therapeutic drugs.
Zhang Z; Guan Q; Tian Y; Shao X; Zhao P; Huang L; Li J
BMC Pulm Med; 2023 Oct; 23(1):373. PubMed ID: 37794454
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathway.
Pan J; Li Y; Wu X; Pan X; Liu C; Zhang H; Wang L; Jiang X; Wang J; Zang N; Pang L; Lv X
J Ethnopharmacol; 2024 Mar; 322():117507. PubMed ID: 38122910
[TBL] [Abstract][Full Text] [Related]
5. Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis.
Machahua C; Vicens-Zygmunt V; Ríos-Martín J; Llatjós R; Escobar-Campuzano I; Molina-Molina M; Montes-Worboys A
Exp Lung Res; 2022 Apr; 48(3):126-136. PubMed ID: 35594338
[No Abstract] [Full Text] [Related]
6. Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach.
Chang J; Zou S; Xiao Y; Zhu D
BMC Complement Med Ther; 2023 Oct; 23(1):352. PubMed ID: 37798725
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of mutual hub genes in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated usual interstitial pneumonia.
Chen L; Lin H; Qin L; Zhang G; Huang D; Chen P; Zhang X
Heliyon; 2024 Apr; 10(7):e28088. PubMed ID: 38571583
[TBL] [Abstract][Full Text] [Related]
8. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
9. Prediction and analysis of genetic effect in idiopathic pulmonary fibrosis and gastroesophageal reflux disease.
Chen P; Xie L; Ma L; Zhao X; Chen Y; Ge Z
IET Syst Biol; 2023 Dec; 17(6):352-365. PubMed ID: 37907428
[TBL] [Abstract][Full Text] [Related]
10. Cub domain-containing protein 1 negatively regulates TGF-β signaling and myofibroblast differentiation.
Noskovičová N; Heinzelmann K; Burgstaller G; Behr J; Eickelberg O
Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L695-L707. PubMed ID: 29351434
[TBL] [Abstract][Full Text] [Related]
11. Identification of Hub Genes and Pathways Associated With Idiopathic Pulmonary Fibrosis
Wan H; Huang X; Cong P; He M; Chen A; Wu T; Dai D; Li W; Gao X; Tian L; Liang H; Xiong L
Front Mol Biosci; 2021; 8():711239. PubMed ID: 34476240
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
[TBL] [Abstract][Full Text] [Related]
13. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
14. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis of the molecular mechanisms in idiopathic pulmonary fibrosis.
Zhu K; Xu A; Xia W; Li P; Han R; Wang E; Zhou S; Wang R
Int J Med Sci; 2021; 18(15):3412-3424. PubMed ID: 34522168
[No Abstract] [Full Text] [Related]
16. Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.
Qian W; Cai X; Qian Q; Zhang X
Biomed Res Int; 2021; 2021():5545312. PubMed ID: 34285914
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.
Velázquez-Enríquez JM; Ramírez-Hernández AA; Navarro LMS; Reyes-Avendaño I; González-García K; Jiménez-Martínez C; Castro-Sánchez L; Sánchez-Chino XM; Vásquez-Garzón VR; Baltiérrez-Hoyos R
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563422
[TBL] [Abstract][Full Text] [Related]
18. Eliglustat exerts anti-fibrotic effects by activating SREBP2 in TGF-β1-treated myofibroblasts derived from patients with idiopathic pulmonary fibrosis.
Kurumiya E; Iwata M; Kasuya Y; Tatsumi K; Honda T; Murayama T; Nakamura H
Eur J Pharmacol; 2024 Mar; 966():176366. PubMed ID: 38296153
[TBL] [Abstract][Full Text] [Related]
19. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
20. Periostin plays a critical role in the cell cycle in lung fibroblasts.
Yoshihara T; Nanri Y; Nunomura S; Yamaguchi Y; Feghali-Bostwick C; Ajito K; Murakami S; Mawatari M; Izuhara K
Respir Res; 2020 Jan; 21(1):38. PubMed ID: 32000779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
